News
05-19-2023, 03:40 PM
Researchers from Rice University and Baylor College of Medicine are hoping a first-of-its-kind "glyco-immune" checkpoint inhibitor could be the key to stopping bone cancer metastasis for breast cancer survivors.
More... (https://www.news-medical.net/news/20230519/Researchers-receive-2423-million-to-continue-development-of-a-new-e28098glyco-immunee28099-checkpoint-inhibitor.aspx)
More... (https://www.news-medical.net/news/20230519/Researchers-receive-2423-million-to-continue-development-of-a-new-e28098glyco-immunee28099-checkpoint-inhibitor.aspx)